Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -6 of 6
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Completed
18 and over
Other
2003-1027
NCT00113334
2.
Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
Pharmaceutical / Industry
M02-534
NCT00061659
3.
Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
Pharmaceutical / Industry
M02-457
NCT00061672
Last Modified:
10/8/2004
 
First Published:
2/20/2004
4.
Phase II Randomized Study of ABT-510 in Patients With Locally Recurrent or Metastatic Renal Cell Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI, Pharmaceutical / Industry
UCLA-0308112
ABBOTT-M02-428, NCT00080704
Last Modified:
1/11/2008
 
First Published:
1/10/2008
5.
Phase II Study of ABT-510 in Patients With Metastatic Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Treatment
Closed
18 and over
NCI
MAYO-MC0375
MC0375, NCT00602199
Last Modified:
8/21/2007
 
First Published:
1/6/2006
6.
Phase I Study of ABT-510 and Bevacizumab in Patients With Advanced Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
NCI
DUMC-6074-05-7R1ER
DUMC-6074, NCT00276562
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute